Thank you to Dr. Quencer and colleagues for an excellent article on primary aldosteronism. 1 I have two questions about testing for primary aldosteronism in patients with atrial fibrillation (AF): The ...

Previously thought to be a rare disease, primary aldosteronism is estimated to affect 5% to 14% of patients with hypertension in the outpatient, primary care setting and 11% to 30% of patients with ...

CHICAGO -- One in 12 patients with incident hypertension screened positive for primary aldosteronism, suggesting expanded screening may boost detection, according to a real-world cohort study. Among 2 ...

Please provide your email address to receive an email when new articles are posted on . Primary aldosteronism, an adrenal disorder and a secondary cause of hypertension, has historically been ...

A simple new method based on the results of two studies from Christofer Juhlin's research group can make it easier to identify the underlying cause of a common form of high blood pressure and help ...

Primary aldosteronism is the leading cause of secondary hypertension, often causing resistant hypertension and increasing cardiovascular and renal risk. It results from excessive aldosterone secretion ...

Primary aldosteronism (otherwise known as PA or Conn Syndrome) is the leading endocrine cause of hypertension (high blood pressure). It carries a higher risk of stroke, heart attack, atrial ...

Please provide your email address to receive an email when new articles are posted on . An updated clinical practice guideline suggested screening all people with hypertension for primary ...

Current treatment options for primary aldosteronism are limited to surgery or mineralocorticoid receptor antagonists when surgery isn't an option. In a phase IIa trial, baxdrostat resolved or reduced ...